Aspen Neuroscience Inc.
Last updated November 3, 2026
Organization details
- Legal name
- Aspen Neuroscience Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ASPE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002124080
Board of directors
-
Andrew Spaventa · DirectorSince 2026
-
Faheem Hasnain · Director · Executive ChairSince 2026
Board connections
1 of this board's directors also sit on 2 other boards.
- via Faheem Hasnain
- via Faheem Hasnain
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $37,999,995
- 4 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Open-market purchase | +66,666 | $15.00 | $999,990 |
| Nov 2, 2026 | ARCH Venture Partners XIV, L.P. 10% owner | Open-market purchase | +1,200,000 | $15.00 | $18,000,000 |
| Nov 2, 2026 | Faheem Hasnain Director, Officer (Executive Chair) | Derivative conversion | +14,913 | — | — |
| Nov 2, 2026 | Andrew Spaventa Director | Derivative conversion | +70,194 | — | — |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Derivative conversion | +187,182 | — | — |
| Nov 2, 2026 | Faheem Hasnain Director, Officer (Executive Chair) | Derivative conversion | +14,316 | — | — |
| Nov 2, 2026 | Andrew Spaventa Director | Derivative conversion | +180,221 | — | — |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Derivative conversion | +298,258 | — | — |
| Nov 2, 2026 | Faheem Hasnain Director, Officer (Executive Chair) | Derivative conversion | +7,120 | — | — |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Derivative conversion | +286,304 | — | — |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Derivative conversion | +295,490 | — | — |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Derivative conversion | +259,948 | — | — |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Open-market purchase | +66,667 | $15.00 | $1,000,005 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Derivative conversion | +298,258 | — | — |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% owner | Derivative conversion | +286,304 | — | — |
Questions about Aspen Neuroscience Inc.
How many directors are on Aspen Neuroscience Inc.'s board?
Aspen Neuroscience Inc.'s board has 2 directors: Andrew Spaventa and Faheem Hasnain.
Are Aspen Neuroscience Inc. insiders buying or selling shares?
Over the last 12 months, Aspen Neuroscience Inc. insiders bought $38.0 million of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="aspen-neuroscience-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.